中文 | English
Return
Total: 198 , 1/20
Show Home Prev Next End page: GO
Author:(Yaping XU)

1.EGFR targeted inhibitors in esophageal cancer

Xiaojiang SUN ; Yaping XU

Journal of International Oncology 2010;37(12):922-925

2.Clinical Observation of Ornidazole Combined with Jinzhi Jieyin Gargle in the Treatment of Acute Wisdom Tooth Pericoronitis

Yaping LI ; Qinghui XU

China Pharmacy 2016;(6):737-739

3.Proceedings of MinK-related peptides

Xianghua XU ; Yaping PAN

Chinese Pharmacological Bulletin 2003;0(10):-

4.Inhibitory effects of survivin antisense oligonucleotide on human endometrial carcinoma cells

Jinyu XU ; Yaping CHEN ; Bingjin CHEN

Fudan University Journal of Medical Sciences 2009;36(6):723-726

5.Application of hypofractionated conformal radiotherapy in non-small cell lung cancer

Liming SHENG ; Yaping XU ; Shenglin MA

Journal of International Oncology 2011;38(5):374-376

6.Diagnosis of the hepatic focal nodular hyperplasia by ultrasonography and CT

Wenping WANG ; Yaping JIANG ; Zhizhang XU

Chinese Journal of Ultrasonography 2001;10(1):32-34

7.Expression of gingipain K in Porphyromonas gingivalis in the subgingival plaque of puberty gingivitis

Xu CHEN ; Yaping PAN ; Zhihong ZONG

Journal of Practical Stomatology 2001;0(03):-

8.Prognostic factors of postoperative radiotherapy for non small cell lung cancer

Yaping XU ; Xiao ZHENG ; Yuan ZHU

Chinese Journal of Radiation Oncology 1992;0(04):-

9.Clinical progress for the EGFR-TKI combined with radiotherapy in non-small cell lung cancer

Juan LIN ; Shuiyun HAN ; Yaping XU

Journal of Chinese Physician 2016;18(6):813-817

10.Proceedings of the two-pore domain K~+ channel

Yaping PAN ; Xianghua XU ; Xiaoliang WANG ;

Chinese Pharmacological Bulletin 1986;0(04):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 198 , 1/20 Show Home Prev Next End page: GO